Related Experiment Videos
Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents
Surgery
|August 1, 1983
Summary
Surgical intervention targeting the hepatic duct bifurcation in sclerosing cholangitis patients significantly improved jaundice. This direct approach offers a viable treatment option for this challenging biliary disease.
Area of Science:
- Hepatology
- Gastroenterology
- Surgical Gastroenterology
Background:
- Sclerosing cholangitis often presents with diffuse biliary strictures, limiting reconstructive surgical options.
- The hepatic duct bifurcation is frequently the most severely narrowed area in patients with sclerosing cholangitis.
Purpose of the Study:
- To evaluate the efficacy of a direct surgical approach for sclerosing cholangitis with hepatic duct bifurcation narrowing.
- To assess outcomes in patients undergoing resection and stenting of the biliary tree.
Main Methods:
- Surgical resection of the extrahepatic biliary tree including the bifurcation in 11 patients.
- Dilation of hepatic ducts, insertion of bilateral transhepatic biliary stents, and hepaticojejunostomy.
- Analysis of pre- and post-operative serum bilirubin levels and clinical activity.
Main Results:
- One hospital death occurred; 9 of 10 surviving patients showed decreased serum bilirubin levels (mean 2.9 mg/dl).
- Nine patients returned to normal activity following the procedure.
- One patient required liver transplantation; follow-up ranged from 4 to 36 months.
Conclusions:
- Direct surgical management of sclerosing cholangitis with bifurcation narrowing is effective in improving jaundice and restoring patient activity.
- Bilateral hepaticojejunostomy with permanent transhepatic biliary stenting is a successful strategy.
- This approach offers a significant improvement over non-surgical management for selected patients.